Starpharma Holdings Ltd
Research Starpharma Holdings Ltd (SPL) on Bullrun: market cap AUD 400.73M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSPL
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryBiotechnology
- CurrencyAUD
- Market capAUD 400.73M
- Financial periodFY2025
- RevenueAUD 4.91M
- Revenue growth-40.7%
- Net income-AUD 9.99M
- Free cash flow-AUD 6.80M
- Gross margin75.1%
Valuation Snapshot
latest market cap is AUD 400.73M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 4.91M | -AUD 9.99M | -AUD 6.80M | 75.1% | -0.02 | AUD 15.41M | AUD 2.40M | AUD 19.00M |
| FY2024 | AUD 8.29M | -AUD 8.17M | -AUD 7.07M | 92.4% | -0.02 | AUD 23.36M | AUD 3.53M | AUD 28.12M |
| FY2023 | AUD 2.94M | -AUD 15.64M | -AUD 14.15M | 61.9% | -0.04 | AUD 35.18M | AUD 8.27M | AUD 34.82M |
| FY2022 | AUD 4.68M | -AUD 16.15M | -AUD 14.00M | 40.7% | -0.04 | AUD 49.92M | AUD 8.19M | AUD 48.39M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-27 | AUD 400.73M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Starpharma Holdings Ltd
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis (BV) and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom coating.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Starpharma Holdings Ltd's market cap?
Starpharma Holdings Ltd's market capitalization is AUD 400.73M.
What does Starpharma Holdings Ltd do?
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis (BV) and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom coating.